Pete Kaufman Reviews The FDA’s Approval Process And Offers a Brief Case Study of The DePuy ASR Hip Implant
The DePuy ASR metal-on-metal hip implant has brought pain to people all across the world who have been victimized by the failure of this device. In August 2010, Johnson & Johnson finally announced the recall of this defective product, which had a shocking failure rate of around 49% after six years of use, according to the British Orthopaedic Association.
These kinds of statistics are unacceptable, and it begs the question: just how did such a potentially dangerous product get allowed onto the market in the first place? In the May issue of Advocate, our firm’s own Pete Kaufman answers that question. In addition to delving into how the product could have come to market without extensive clinical testing and how such a device would have been approved by the Food and Drug Administration in the first place, Kaufman discusses the essential tactics that a plaintiff’s legal team must utilize in order to gain proper compensation for the victim.